Liven Pharma Limited (PSX:LIVEN)
32.38
+0.08 (0.25%)
At close: Sep 9, 2026
Liven Pharma Market Cap
Liven Pharma has a market cap or net worth of 3.65 billion as of September 9, 2026. Its market cap has decreased by -38.10% in one year.
Market Cap
3.65B
Enterprise Value
3.50B
Revenue
99.11M
Ranking
n/a
PE Ratio
n/a
Stock Price
32.38
ChartMarket Cap Chart
Since November 2, 2004, Liven Pharma's market cap has increased from 78.80M to 3.65B, an increase of 4,533.27%. That is a compound annual growth rate of 19.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 3.65B | -24.49% |
| Dec 31, 2025 | 4.84B | 164.93% |
| Dec 31, 2024 | 1.83B | 840.88% |
| Dec 26, 2023 | 193.98M | -25.16% |
| Dec 30, 2021 | 259.20M | 49.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pakistan Engineering Company | 3.81B |
| Ghani ChemWorld | 3.78B |
| Macpac Films | 3.74B |
| Mitchell's Fruit Farms | 3.71B |
| Symmetry Group | 3.65B |
| The National Silk & Rayon Mills | 3.64B |
| First Habib Modaraba | 3.59B |
| Exide Pakistan | 3.56B |